Effects of hydroxyethyl starch (130kD) on brain inflammatory response and outcome during normotensive sepsis

International Immunopharmacology

Volumn 10, Issue 8, 2010, Pages 859-864

  Feng, Xiaomei ^a   Zhang, Fujun ^a   Dong, Rong ^a   Wang, Haibin ^a   Liu, Jian ^a,b   Liu, Xuesheng ^a   Li, Weiyan ^b   Yao, Jingxin ^a   Xu, Jianguo ^b   Yu, Buwei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Blood brain barrier permeability; Hydroxyethyl starch 130 0.4; Nuclear factor kappa B; TNF ; Toll like receptor

Indexed keywords

EVANS BLUE; HETASTARCH; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRY WEIGHT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAVASATION; GEL MOBILITY SHIFT ASSAY; HUMAN; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCTURE; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; WEIGHT REDUCTION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENCEPHALITIS; HETASTARCH; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; TYPHLITIS;

EID: 77954956543     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.04.020     Document Type: Article

References (35)

1. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., Moreno R., Carlet J., Le Gall J.R., Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353.
2. Vandijck D., Decruyenaere J.M., Blot S.I. The value of sepsis definitions in daily ICU-practice. Acta Clin Belg 2006, 6:220-226.
3. Semmler A., Hermann S., Mormann F., Weberpals M., Paxian S.A., Okulla T., Schafers M., Kummer M.P., Klockgether T., Heneka M.T. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation 2008, 5:38.
4. Alexander J.J., Jacob A., Cunningham P., Hensley L., Quigg R.J. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int 2008, 52:447-456.
5. Wratten M.L. Therapeutic approaches to reduce systemic inflammation in septic-associated neurologic complications. Eur J Anaesthesiol Suppl 2008, 42:1-7.
6. Hofer S., Bopp C., Hoerner C., Plaschke K., Faden R.M., Martin E., Bardenheuer H.J., Weigand M.A. Injury of the blood brain barrier and up-regulation of ICAM-1 in polymicrobial sepsis. J Surg Res 2008, 146:276-281.
7. Sharshar T., Hopkinson N.S., Orlikowski D., Annane D. Science review: the brain in sepsis - culprit and victim. Crit Care 2005, 9:37-44.
8. Hanisch U.K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
9. Ghirnikar R.S., Lee Y.L., Eng L.F. Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem Res 1998, 23:329-340.
10. Lynch N.J., Willis C.L., Nolan C.C., Roscher S., Fowler M.J., Weihe E., Ray D.E., Schwaeble W.J. Microglial activation and increased synthesis of complement component C1q precedes blood brain barrier dysfunction in rats. Mol Immunol 2004, 40:709-716.
11. Alexander J.J., Jacob A., Cunningham P., Hensley L., Quigg R.J. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int 2008, 52:447-456.
12. Stenzel W., Soltek S., Sanchez-Ruiz M., Akira S., Miletic H., Schlüter D., Deckert M. Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess. Am J Pathol 2008, 172:132-145.
13. Freudenberg M.A., Tchaptchet S., Keck S., Fejer G., Huber M., Schütze N., Beutler B., Galanos C. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. Immunobiology 2008, 213:193-203.
14. Kimbrell M.R., Warshakoon H., Cromer J.R., Malladi S., Hood J.D., Balakrishna R., Scholdberg T.A., David S.A. Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells. Immunol Lett 2008, 118:132-141.
15. Tsujimoto H., Ono S., Efron P.A., Scumpia P.O., Moldawer L.L., Mochizuki H. Role of Toll-like receptors in the development of sepsis. Shock 2008, 29:315-321.
16. Barton G.M., Medzhotov R. Toll-like receptor signaling pathways. Science 2003, 300:1524-1525.
17. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14.
18. Baluna R., Vitetta E.S. Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology 1997, 37:117-132.
19. Boldt J., Brosch C., Ducke M., Papsdorf M., Lehmann A. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 2007, 35:2740-2746.
20. Xiong L., Lei C., Wang Q., Li W. Acute normovolaemic haemodilution with a novel hydroxyethyl starch (130/0.4) reduces focal cerebral ischaemic injury in rats. Eur J Anaesthesiol 2008, 25:581-588.
21. Boldt J., Brosch Ch., Röhm K., Papsdorf M., Mengistu A. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 2008, 100:457-464.
22. Feng X., Ren B., Xie W., Huang Z., Liu J., Guan R., Duan M., Xu J. Influence of hydroxyethyl starch 130/0.4 in pulmonary neutrophil recruitment and acute lung injury during polymicrobial sepsis in rats. Acta Anaesthesiol Scand 2006, 50:1081-1088.
23. Feng X., Yan W., Wang Z., Liu J., Min Yu., Zhu S., Xu J. Hydroxyethyl starch, but not modified fluid gelatin, affects inflammatory response in a rat model of polymicrobial sepsis with capillary leakage. Anesth Analg 2007, 104:624-630.
24. Feng X., Yan W., Liu X., Duan M., Zhang X., Xu J. Effects of hydroxyethyl starch 130/0.4 on pulmonary capillary leakage and cytokines production and NF-kappaB activation in CLP-induced sepsis in rats. J Surg Res 2006, 135:129-136.
25. Feng X., Hu Y., Ding J., Ge Y., Song J., Ai Q., Zhang Z., Xu J. Early treatment with hydroxyethyl starch 130/0.4 causes greater inhibition of pulmonary capillary leakage and inflammatory response than treatment instituted later in sepsis induced by cecal ligation and puncture in rats. Ann Clin Lab Sci 2007, 37:49-56.
26. Feng X., Liu J., Yu M., Zhu S., Xu J. Protective roles of hydroxyethyl starch 130/0.4 in intestinal inflammatory response and survival in rats challenged with polymicrobial sepsis. Clin Chim Acta 2007, 376:60-67.
27. Xie J., Lv R., Yu L., Huang W. Hydroxyethyl starch 130/0.4 inhibits production of plasma proinflammatory cytokines and attenuates nuclear factor-kappaB activation and Toll-like receptors expression in monocytes during sepsis. J Surg Res 2010, 160:133-138.
28. Stenzel W., Soltek S., Miletic H., Hermann M.M., Korner H., Sedgwick J.D., Schluter D., Deckert M. An essential role for tumor necrosis factor in the formation of experimental murine Staphylococcus aureus-induced brain abscess and clearance. J Neuropathol Exp Neurol 2005, 64:27-36.
29. Chi O.Z., Lu X., Wei H.M., Williams J.A., Weiss H.R. Hydroxyethyl starch solution attenuates blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Anesth Analg 1996, 83:336-341.
30. Dieterich H.J., Reutershan J., Felbinger T.W., Eltzschig H.K. Penetration of intravenous hydroxyethyl starch into the cerebrospinal fluid in patients with impaired blood-brain barrier function. Anesth Analg 2003, 96:1150-1154.
31. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
32. Rankine E.L., Hughes P.M., Botham M.S., Perry V.H., Felton L.M. Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment. Eur J Neurosci 2006, 24:77-86.
33. Semmler A., Frisch C., Debeir T., Ramanathan M., Okulla T., Klockgether T., Heneka M.T. Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp Neurol 2007, 204:733-740.
34. Senftleben U., Karin M. The IKK/NF-κB pathway. Crit Care Med 2002, 30:S18-S26.
35. Rieckmann P., Michel U., Albrecht M., Bruck W., Wockel L., Felgenhauer K. Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system. Neurosci Lett 1995, 186:61-64.